Sepsis is the leading cause of death in U.S. hospitals, with more than one-third of all in-hospital deaths attributed to the condition. About 80% of sepsis patients present to emergency departments, where it can be difficult to discern from ordinary infections or other conditions that can mimic sepsis.

“The Froedtert & MCW health network is committed to offering patients the best care and a definitive test is a valuable addition to our sepsis management program. A team of Medical College of Wisconsin researchers has worked closely with Cytovale over the years. We see the potential impact a sepsis test can have on improving patient care and streamlining efficiencies in hospital operations,” said Nathan Ledeboer, Ph.D., Medical College of Wisconsin chief of Clinical Pathology and associate chief medical laboratory officer for the Froedtert & MCW health network.

“We are well aware of the difficulty in identifying potentially septic patients when they present to our ED. Any tool that we can deploy during ED triage to ensure that patients get the care that they need is invaluable. This is the first blood test our clinicians have ever had in their toolbox that provides valuable insight into a patient’s immune system to detect sepsis earlier and make more informed treatment decisions,” he added.